Champlain Investment Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156M | Sell |
1,791,100
-71,320
| -4% | -$6.23M | 1.09% | 29 |
|
|
2025
Q1 | $127M | Sell |
1,862,420
-153,293
| -8% | -$10.5M | 0.92% | 38 |
|
|
2024
Q4 | $157M | Sell |
2,015,713
-197,570
| -9% | -$15.4M | 0.99% | 32 |
|
|
2024
Q3 | $148M | Buy |
2,213,283
+163,210
| +8% | +$10.9M | 0.9% | 41 |
|
|
2024
Q2 | $232M | Sell |
2,050,073
-6,080
| -0.3% | -$689K | 1.43% | 15 |
|
|
2024
Q1 | $285M | Sell |
2,056,153
-53,830
| -3% | -$7.47M | 1.63% | 8 |
|
|
2023
Q4 | $262M | Sell |
2,109,983
-47,735
| -2% | -$5.92M | 1.55% | 11 |
|
|
2023
Q3 | $201M | Buy |
2,157,718
+264,220
| +14% | +$24.7M | 1.31% | 16 |
|
|
2023
Q2 | $243M | Buy |
1,893,498
+6,110
| +0.3% | +$785K | 1.5% | 15 |
|
|
2023
Q1 | $219M | Buy |
1,887,388
+115,429
| +7% | +$13.4M | 1.38% | 15 |
|
|
2022
Q4 | $201M | Sell |
1,771,959
-13,705
| -0.8% | -$1.55M | 1.29% | 17 |
|
|
2022
Q3 | $144M | Buy |
1,785,664
+275,086
| +18% | +$22.2M | 0.98% | 34 |
|
|
2022
Q2 | $113M | Buy |
1,510,578
+934,258
| +162% | +$69.6M | 0.73% | 60 |
|
|
2022
Q1 | $73.7M | Buy |
+576,320
| New | +$73.7M | 0.38% | 98 |
|